AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$1.58B |
| 2 |
McKesson
MCK
|
+$961M |
| 3 |
Applied Materials
AMAT
|
+$903M |
| 4 |
Microsoft
MSFT
|
+$749M |
| 5 |
Progressive
PGR
|
+$743M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$1.13B |
| 2 |
Arista Networks
ANET
|
+$1.09B |
| 3 |
Costco
COST
|
+$1.03B |
| 4 |
Tractor Supply
TSCO
|
+$550M |
| 5 |
Amazon
AMZN
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.3% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.56% |
| 5 | Communication Services | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Coherus Oncology
CHRS
$217M
| $156K | ﹤0.01% |
213,590
+25,180
| +13% | +$21.7K |
|
3102
AudioEye
AEYE
$70.8M
| $156K | ﹤0.01% |
+13,380
| New | +$159K |
|
3103
Vivid Seats
SEAT
$77M
| $154K | ﹤0.01% |
4,558
+555
| +14% | +$23.8K |
|
3104
Pangaea Logistics
PANL
$501M
| $154K | ﹤0.01% |
32,710
+13,800
| +73% | +$61.3K |
|
3105
Cardiff Oncology
CRDF
$64.3M
| $154K | ﹤0.01% |
48,730
+38,350
| +369% | +$117K |
|
3106
Dakota Gold
DC
$623M
| $153K | ﹤0.01% |
41,590
+20,000
| +93% | +$62.5K |
|
3107
Entrada Therapeutics
TRDA
$227M
| $153K | ﹤0.01% |
22,700
+9,930
| +78% | +$79.9K |
|
3108
Design Therapeutics
DSGN
$736M
| $152K | ﹤0.01% |
45,030
+2,940
| +7% | +$11K |
|
3109
Melco Resorts & Entertainment
MLCO
$2.1B
| $150K | ﹤0.01% |
20,707
| – | – |
|
3110
Nkarta
NKTX
$162M
| $149K | ﹤0.01% |
89,870
+9,180
| +11% | +$16.8K |
|
|
SVM
3111
Silvercorp Metals
SVM
$2.13B
| $147K | ﹤0.01% |
34,800
| – | – |
|
3112
Gyre Therapeutics
GYRE
$662M
| $146K | ﹤0.01% |
+19,930
| New | +$174K |
|
3113
Satellogic
SATL
$532M
| $146K | ﹤0.01% |
+40,380
| New | +$152K |
|
3114
Ironwood Pharmaceuticals
IRWD
$611M
| $143K | ﹤0.01% |
199,520
+46,960
| +31% | +$36.9K |
|
|
SUNS
3115
Sunrise Realty Trust
SUNS
$108M
| $143K | ﹤0.01% |
+13,472
| New | +$140K |
|
|
AFCG
3116
AFC Gamma
AFCG
$58.6M
| $142K | ﹤0.01% |
31,800
+7,900
| +33% | +$40.7K |
|
3117
InnovAge Holding
INNV
$1.57B
| $141K | ﹤0.01% |
38,300
+2,000
| +6% | +$7K |
|
|
PBPB
3118
DELISTED
Potbelly
PBPB
| $137K | ﹤0.01% |
+11,170
| New | +$110K |
|
3119
Pulmonx
LUNG
$49.4M
| $135K | ﹤0.01% |
52,200
+3,600
| +7% | +$14.2K |
|
3120
Acacia Research
ACTG
$450M
| $135K | ﹤0.01% |
37,740
+5,400
| +17% | +$18.6K |
|
3121
American Vanguard Corp
AVD
$73.5M
| $135K | ﹤0.01% |
34,420
+4,800
| +16% | +$20K |
|
3122
Backblaze
BLZE
$697M
| $135K | ﹤0.01% |
+24,500
| New | +$125K |
|
3123
Concrete Pumping Holdings
BBCP
$531M
| $135K | ﹤0.01% |
21,890
+8,430
| +63% | +$53.5K |
|
3124
Sight Sciences
SGHT
$267M
| $135K | ﹤0.01% |
32,580
+3,300
| +11% | +$11K |
|
3125
AlTi Global
ALTI
$378M
| $134K | ﹤0.01% |
32,360
+10,500
| +48% | +$36.2K |
|
Similar funds
AllianceBernstein's Q2 2025 Portfolio in Review
As of Q2 2025, AllianceBernstein held 3,383 positions worth $307B, up 11% from $276B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
AllianceBernstein's Q2 2025 filing shows 182 new, 1,436 increased, 1,245 reduced and 150 closed positions. Its largest new stake was Star Bulk Carriers: 3,765,155 shares worth $64.9M. The largest sale was Zoetis, an estimated $1.13B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q2 2025 buy was Star Bulk Carriers: 3,765,155 shares worth $64.9M.
- AllianceBernstein added most to Stryker in Q2 2025, an estimated $1.58B increase.
- AllianceBernstein's biggest Q2 2025 reduction was Zoetis, cutting an estimated $1.13B.
- AllianceBernstein fully exited Discover Financial Services in Q2 2025, selling an estimated $123M.
- AllianceBernstein's ten largest holdings make up 32% of its $307B portfolio in Q2 2025.
- AllianceBernstein opened 182 new positions and closed 150 in Q2 2025.
- AllianceBernstein's portfolio value rose 11% quarter-over-quarter to $307B.
Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.